LWBK1006-Index LWW-Govindan-Review December 19, 2011 19:14
618 IndexQuality of life, cancer and, 561–572
Quetelet’s Index, 61, 66
calculation of, 61, 66
Quiescence, 13Radiation
acute effect of, 86, 91
ankylosing spondylitis treatment
by, 59, 64
depth dose characteristics of, 88,
93
dose and cancer risk, 59, 65
enlarged thymus glands treatment
by, 59, 64
peptic ulcers treatment by, 59, 64
Radiation-induced heart disease,
554, 558
Radiation-induced hyposalivation,
treatment of, 573, 577
Radiation pneumonitis, 554, 558
Radiation Therapy Oncology
Group (RTOG), 87, 92, 249
Radiation therapy (RT), 334, 343
Radical cystectomy, 282, 290
Radical nephrectomy, 291
Radioactive iodine ablation, for
papillary carcinoma, 350,
358–359
Radioactive nucleotides and
metastasis, 30
Radiologic imaging, 366, 371
Radionuclide treatment, of bone
metastases, 511, 514
Radiotherapy, in mediastinal
seminoma, 227
Radiotherapy (RT), 416
Radon, 60, 65
Raloxifene, 136, 139
Randomized treatment assignment,
186, 192–193
Rasburicase, 504, 507
Ras protein, 16
Rb1.SeeRetinoblastoma protein
(Rb1)
RBC.SeeRed blood cell (RBC)
RBE.SeeRelative biological
effectiveness (RBE)
R-CHOP, in lymphoma treatment,
418, 431–432
REAL.SeeRevised
European–American
Lymphoma (REAL)
Recall bias and cancer, 61, 66
Receptor phosphotyrosine
phosphatases (RPTP), 7, 15
Receptor tyrosine kinases, 6, 15
RECIST.SeeResponse Evaluation
Criteria in Solid Tumors
(RECIST)Recombinant growth factor, 571
Recreational therapists, 577
Rectal cancer
neoadjuvant chemoradiotherapy
in, 271, 276
transanal excision for, 271, 276
Rectal primary, 512, 514–515
Red blood cell (RBC), 21
Red clover, 592, 596
Redistribution, 86, 91
Red meat consumption and
colorectal cancer, 62, 67
Rehabilitation, of cancer patients,
573–579
indication for, 575, 578
Relative biological effectiveness
(RBE), 85, 90
Relative risk, 71, 75
Renal cell cancer
and clear cell histology, 108, 112
MET mutation and, 279, 288
orthopedic resection, 280, 288
poor-risk features in, 280, 289
treatment, interferon-in, 280,
289
types of, 288
Renal cell carcinoma,
erythrocytosis and, 518, 522
Renal pelvis urothelial cancers,
radical nephroureterectomy
in, 283, 291
Reoxygenation, 86, 91
Repair, 86, 91
Repopulation, 86, 91
Re-resection for cancer treatment,
366, 371
Resection, 368, 373
limb-sparing, 367, 371
of primary tumor, 371
Response Evaluation Criteria in
Solid Tumors (RECIST), 166,
177, 498
criteria, limitations of, 99, 103
Retinoblastoma, 394, 404
cytogenetic abnormalities with,
403, 412
risk of dissemination of, 408
side effects of therapy for, 399,
409
staging studies for, 398, 408
transmission of, genetics of, 398,
408
vision-sparing interventions in,
408
Retinoblastoma protein (Rb1), 35,
45
E2F transcription proteins and,
35, 45
105-kDa protein and, 35, 45Retinoic acid receptor alpha, 438,
443–444.See alsoLeukemias
Retinopathy, melanoma-associated,
520, 524
RET proto-oncogene mutation,
355, 362
Retroperitoneal lymph node
resection (RPLND), 298, 302
Retrovirus, 37, 48
Revised European–American
Lymphoma (REAL), 423
Rhabdomyosarcoma (RMS)
alveolar, 395, 405
embryonal, 395, 399, 405, 409
inherited cancer syndromes with,
399, 409
staging studies for, 399, 409
treatment of, 400, 409–410
Rhizotomy, 562, 567
Ribavirin, in HCC treatment, 50
Rib belts, for pain control, 578
R-ICE.SeeRituximab-ifosfamide,
cisplatin, and etoposide
(R-ICE)
Rituxan maintenance therapy, 430
Rituximab-ifosfamide, cisplatin,
and etoposide (R-ICE), 418
Rituximab, role of, 498, 500
Robotic laparoscopic
prostatectomy, 285, 293
Rofecoxib, 139
RPLND.SeeRetroperitoneal lymph
node resection (RPLND)
RPTP.SeeReceptor
phosphotyrosine phosphatases
(RPTP)
RSR13, use of, 511, 514
RT.SeeRadiation therapy (RT);
Radiotherapy (RT)
RTOG.SeeRadiation Therapy
Oncology Group (RTOG)
RUNX1-RUNX1T1, 437, 443Salvage chemotherapy, 300, 303
Sarcomas
angiosarcoma, 366, 371
chondrosarcoma, 368, 373
clonal cytogenetic abnormality in,
365, 370
cytogenetic abnormality, 365,
369, 370
Ewing’s, 369, 370
imaging for, 367
leiomyosarcoma, 367
liposarcoma, high-grade, 367
management of cancer, 366, 371
osteosarcoma, 368, 373
radiation-induced, 365, 370
risk of death, 366, 370